In rheumatoid arthritis, IL-17 cooperates with TNF and IL-6 to promote synovial fibroblast activation, RANKL upregulation, and erosive damage with synovial tissue atlases identifying Th17-related inflammatory neighborhoods that may modulate treatment response [13,35,36]. Here, IL17A is linked to rheumatoid arthritis.